Literature DB >> 27280334

Association of a type 2 diabetes genetic risk score with insulin secretion modulated by insulin sensitivity among Chinese Hans.

X Kong1, X Xing1, J Hong1, X Zhang1, W Yang1.   

Abstract

Type 2 diabetes (T2D) is characterized by insulin resistance and impaired insulin secretion. The present study aimed to identify the influence of insulin sensitivity on the genetic risk of impaired insulin secretion among a Chinese Han population. For 3229 controls and 1994 treatment-naïve T2D, single nucleotide polymorphisms (SNPs) from 24 T2D-related genomic loci were genotyped and a genetic risk score (GRS) was constructed. Results showed that GRS was associated with insulin secretion and disposition indices in both controls and treatment-naïve T2Ds. Upon stratifying the participants into tertiles by the Matsuda index, we observed an inhibitory relationship between the GRS and insulin secretion in low insulin sensitive but not in high insulin sensitive controls and treatment-naïve T2Ds. Moreover, low insulin sensitive individuals exhibited more severe impairment in insulin secretion and beta cell response to insulin sensitivity with an increase in risk alleles. Our findings identified that the association of GRS with insulin secretion was strongly modulated by insulin sensitivity in both controls and T2Ds of Chinese Han. It indicates that insulin sensitization should be emphasized in prevention and treatment of T2D for beta cell protection.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  genetics of type 2 diabetes; insulin secretion in vivo; insulin sensitivity and resistance; single nucleotide polymorphism

Mesh:

Substances:

Year:  2016        PMID: 27280334      PMCID: PMC5148717          DOI: 10.1111/cge.12817

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  40 in total

Review 1.  Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.

Authors:  S E Kahn
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

2.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

Authors:  Struan F A Grant; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Andrei Manolescu; Jesus Sainz; Agnar Helgason; Hreinn Stefansson; Valur Emilsson; Anna Helgadottir; Unnur Styrkarsdottir; Kristinn P Magnusson; G Bragi Walters; Ebba Palsdottir; Thorbjorg Jonsdottir; Thorunn Gudmundsdottir; Arnaldur Gylfason; Jona Saemundsdottir; Robert L Wilensky; Muredach P Reilly; Daniel J Rader; Yu Bagger; Claus Christiansen; Vilmundur Gudnason; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

3.  Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice.

Authors:  Fan-Yan Wei; Takeo Suzuki; Sayaka Watanabe; Satoshi Kimura; Taku Kaitsuka; Atsushi Fujimura; Hideki Matsui; Mohamed Atta; Hiroyuki Michiue; Marc Fontecave; Kazuya Yamagata; Tsutomu Suzuki; Kazuhito Tomizawa
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

4.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

5.  TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals.

Authors:  O Le Bacquer; J Kerr-Conte; S Gargani; N Delalleau; M Huyvaert; V Gmyr; P Froguel; B Neve; F Pattou
Journal:  Diabetologia       Date:  2012-08-22       Impact factor: 10.122

6.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

Review 7.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Authors:  S E Kahn
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

8.  Genetic risk score constructed using 14 susceptibility alleles for type 2 diabetes is associated with the early onset of diabetes and may predict the future requirement of insulin injections among Japanese individuals.

Authors:  Minoru Iwata; Shiro Maeda; Yutaka Kamura; Atsuko Takano; Hiromi Kato; Shihou Murakami; Kiyohiro Higuchi; Atsushi Takahashi; Hayato Fujita; Kazuo Hara; Takashi Kadowaki; Kazuyuki Tobe
Journal:  Diabetes Care       Date:  2012-06-11       Impact factor: 19.112

9.  Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

Authors:  Eleftheria Zeggini; Michael N Weedon; Cecilia M Lindgren; Timothy M Frayling; Katherine S Elliott; Hana Lango; Nicholas J Timpson; John R B Perry; Nigel W Rayner; Rachel M Freathy; Jeffrey C Barrett; Beverley Shields; Andrew P Morris; Sian Ellard; Christopher J Groves; Lorna W Harries; Jonathan L Marchini; Katharine R Owen; Beatrice Knight; Lon R Cardon; Mark Walker; Graham A Hitman; Andrew D Morris; Alex S F Doney; Mark I McCarthy; Andrew T Hattersley
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

10.  Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.

Authors:  Kristina M Utzschneider; Ronald L Prigeon; Mirjam V Faulenbach; Jenny Tong; Darcy B Carr; Edward J Boyko; Donna L Leonetti; Marguerite J McNeely; Wilfred Y Fujimoto; Steven E Kahn
Journal:  Diabetes Care       Date:  2008-10-28       Impact factor: 19.112

View more
  6 in total

1.  Long non-coding RNA LY86-AS1 and HCG27_201 expression in type 2 diabetes mellitus.

Authors:  Leyla Saeidi; Hamid Ghaedi; Mirsaber Sadatamini; Rouhollah Vahabpour; Ali Rahimipour; Mehrnoosh Shanaki; Zahra Mansoori; Faranak Kazerouni
Journal:  Mol Biol Rep       Date:  2018-10-16       Impact factor: 2.316

2.  Effects of variants of 50 genes on diabetes risk among the Chinese population born in the early 1960s.

Authors:  Chao Song; Meng Wang; Hongyun Fang; Weiyan Gong; Deqian Mao; Caicui Ding; Qiqi Fu; Ganyu Feng; Zheng Chen; Yanning Ma; Yecheng Yao; Ailing Liu
Journal:  J Diabetes       Date:  2019-04-25       Impact factor: 4.006

3.  PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus.

Authors:  Tao Wang; Jin-Fang Song; Xue-Yan Zhou; Cheng-Lin Li; Xiao-Xing Yin; Qian Lu
Journal:  BMC Med Genomics       Date:  2021-11-12       Impact factor: 3.063

4.  Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus.

Authors:  Jinfang Song; Na Li; Ruonan Hu; Yanan Yu; Ke Xu; Hongwei Ling; Qian Lu; Tingting Yang; Tao Wang; Xiaoxing Yin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-16       Impact factor: 6.055

5.  Hematopoietically expressed homeobox gene is associated with type 2 diabetes in KK Cg-Ay/J mice and a Taiwanese Han Chinese population.

Authors:  Chi-Cheng Lu; Yng-Tay Chen; Shih-Yin Chen; Yuan-Man Hsu; Chyi-Chyang Lin; Je-Wei Tsao; Yu-Ning Juan; Jai-Sing Yang; Fuu-Jen Tsai
Journal:  Exp Ther Med       Date:  2018-05-10       Impact factor: 2.447

6.  MTNR1B Gene Polymorphisms Are Associated With the Therapeutic Responses to Repaglinide in Chinese Patients With Type 2 Diabetes Mellitus.

Authors:  Tao Wang; Xiao-Tong Wang; Ran Lai; Hong-Wei Ling; Fan Zhang; Qian Lu; Dong-Mei Lv; Xiao-Xing Yin
Journal:  Front Pharmacol       Date:  2019-11-07       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.